-
1.Substituted 7,8-dihydro-1H-pyrimido[4,5-b][1,4]diazepin-4-amines are novel kinase inhibitors 有权
标题翻译: 取代的7,8-二氢-1H-嘧啶并[4,5-b] [1,4]二氮杂-4-胺是新的激酶抑制剂公开(公告)号:US20060270663A1
公开(公告)日:2006-11-30
申请号:US11432931
申请日:2006-05-12
申请人: Vijaya Gracias , Celerino Abad-Zapatero , Stevan Djuric , Zhiqin Ji , Michael Michaelides , Kent Stewart , Irini Zanze
发明人: Vijaya Gracias , Celerino Abad-Zapatero , Stevan Djuric , Zhiqin Ji , Michael Michaelides , Kent Stewart , Irini Zanze
IPC分类号: A61K31/551 , C07D487/02
CPC分类号: C07D487/04
摘要: Compounds having the Formula (I) are useful for inhibiting protein tyrosine kinases. The present invention also discloses methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.
摘要翻译: 具有式(I)的化合物可用于抑制蛋白酪氨酸激酶。 本发明还公开了制备化合物的方法,含有该化合物的组合物和使用该化合物的处理方法。
-
2.Pharmaceutical Compositions as Inhibitors of Dipeptidyl Peptidase-IV (DPP-IV) 审中-公开
标题翻译: 药物组合物作为二肽基肽酶-IV抑制剂(DPP-IV)公开(公告)号:US20070238753A1
公开(公告)日:2007-10-11
申请号:US11757173
申请日:2007-06-01
申请人: David Madar , Stevan Djuric , Melissa Michmerhuizen , Hana Kopecka , Xiaofeng Li , Kenton Longenecker , Zhonghua Pei , Daisy Pireh , Hing Sham , Kent Stewart , Bruce Szczepankiewicz , Paul Wiedeman , Hong Yong
发明人: David Madar , Stevan Djuric , Melissa Michmerhuizen , Hana Kopecka , Xiaofeng Li , Kenton Longenecker , Zhonghua Pei , Daisy Pireh , Hing Sham , Kent Stewart , Bruce Szczepankiewicz , Paul Wiedeman , Hong Yong
IPC分类号: A61K31/40 , A61K31/44 , A61K31/445 , A61P3/10 , C07D207/00 , C07D207/02 , C07D401/00
CPC分类号: C07D207/16
摘要: The present invention relates to compounds that inhibit dipeptidyl peptidase IV (DPP-IV) and are useful for the prevention or treatment of diabetes, especially type II diabetes, as well as hyperglycemia, Syndrome X, hyperinsulinemia, obesity, atherosclerosis, and various immunomodulatory diseases.
摘要翻译: 本发明涉及抑制二肽基肽酶IV(DPP-IV)并可用于预防或治疗糖尿病,特别是II型糖尿病以及高血糖症,X综合症,高胰岛素血症,肥胖症,动脉粥样硬化和各种免疫调节疾病的化合物 。
-
3.PHARMACEUTICAL COMPOSITIONS AS INHIBITORS OF DIPEPTIDYL PEPTIDASE-IV (DPP-IV) 审中-公开
标题翻译: 作为DIPPTIDYL PEPTIDASE-IV(DPP-IV)抑制剂的药物组合物公开(公告)号:US20070265302A1
公开(公告)日:2007-11-15
申请号:US11828099
申请日:2007-07-25
申请人: David Madar , Stevan Djuric , Melissa Michmerhuizen , Hana Kopecka , Xiaofeng Li , Kenton Longenecker , Zhonghua Pei , Daisy Pireh , Hing Sham , Kent Stewart , Bruce Szezepankiewicz , Paul Wiedeman , Hong Yong
发明人: David Madar , Stevan Djuric , Melissa Michmerhuizen , Hana Kopecka , Xiaofeng Li , Kenton Longenecker , Zhonghua Pei , Daisy Pireh , Hing Sham , Kent Stewart , Bruce Szezepankiewicz , Paul Wiedeman , Hong Yong
IPC分类号: A61K31/47 , A61K31/40 , A61P3/08 , C07D211/00 , C07D215/00 , C07D207/04 , A61K31/445
CPC分类号: C07D207/27 , C07D207/16 , C07D401/06 , C07D401/12 , C07D401/14 , C07D403/12 , C07D405/12 , C07D417/12
摘要: The present invention relates to compounds which inhibit dipeptidyl peptidase IV (DPP-IV) and are useful for the prevention or treatment of diabetes, especially type II diabetes, as well as hyperglycemia, Syndrome X, hyperinsulinemia, obesity, atherosclerosis, and various immunomodulatory diseases.
摘要翻译: 本发明涉及抑制二肽基肽酶IV(DPP-IV)的化合物,其可用于预防或治疗糖尿病,特别是II型糖尿病,以及高血糖症,X综合征,高胰岛素血症,肥胖,动脉粥样硬化和各种免疫调节疾病 。
-
4.Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) 失效
标题翻译: 药物组合物作为二肽基肽酶-IV(DPP-IV)的抑制剂公开(公告)号:US20050215784A1
公开(公告)日:2005-09-29
申请号:US11036258
申请日:2005-01-13
申请人: David Madar , Stevan Djuric , Melissa Michmerhuizen , Hana Kopecka , Xiaofeng Li , Kenton Longenecker , Zhonghua Pei , Daisy Pireh , Hing Sham , Kent Stewart , Bruce Szczepankiewicz , Paul Wiedeman , Hong Yong
发明人: David Madar , Stevan Djuric , Melissa Michmerhuizen , Hana Kopecka , Xiaofeng Li , Kenton Longenecker , Zhonghua Pei , Daisy Pireh , Hing Sham , Kent Stewart , Bruce Szczepankiewicz , Paul Wiedeman , Hong Yong
IPC分类号: A61K31/551 , C07D207/16 , C07D207/26 , C07D207/27 , C07D401/06 , C07D401/12 , C07D401/14 , C07D403/12 , C07D405/12 , C07D413/02 , C07D417/02 , C07D417/12 , C07D43/02
CPC分类号: C07D207/16 , C07D207/27 , C07D401/06 , C07D401/12 , C07D401/14 , C07D403/12 , C07D405/12 , C07D417/12
摘要: The present invention relates to compounds that inhibit dipeptidyl peptidase IV (DPP-IV) and are useful for the prevention or treatment of diabetes, especially type II diabetes, as well as hyperglycemia, Syndrome X, hyperinsulinemia, obesity, atherosclerosis, and various immunomodulatory diseases.
摘要翻译: 本发明涉及抑制二肽基肽酶IV(DPP-IV)并可用于预防或治疗糖尿病,特别是II型糖尿病以及高血糖症,X综合症,高胰岛素血症,肥胖症,动脉粥样硬化和各种免疫调节疾病的化合物 。
-
公开(公告)号:US20050107364A1
公开(公告)日:2005-05-19
申请号:US10925072
申请日:2004-08-24
申请人: Douglas Hutchinson , John Bellettini , David Betebenner , Richard Bishop , Thomas Borchardt , Todd Bosse , Russell Cink , Charles Flentge , Bradley Gates , Brian Green , Mira Hinman , Peggy Huang , Larry Klein , Allan Krueger , Daniel Larson , M. Leanna , Dachun Liu , Darold Madigan , Keith McDaniel , John Randolph , Todd Rockway , Teresa Rosenberg , Kent Stewart , Vincent Stoll , Rolf Wagner , Ming Yeung
发明人: Douglas Hutchinson , John Bellettini , David Betebenner , Richard Bishop , Thomas Borchardt , Todd Bosse , Russell Cink , Charles Flentge , Bradley Gates , Brian Green , Mira Hinman , Peggy Huang , Larry Klein , Allan Krueger , Daniel Larson , M. Leanna , Dachun Liu , Darold Madigan , Keith McDaniel , John Randolph , Todd Rockway , Teresa Rosenberg , Kent Stewart , Vincent Stoll , Rolf Wagner , Ming Yeung
IPC分类号: A61K31/549 , C07D285/26
CPC分类号: C07D207/08 , C07C323/22 , C07C323/56 , C07C323/60 , C07C2601/02 , C07C2601/04 , C07C2601/08 , C07C2601/14 , C07C2602/10 , C07D263/14 , C07D285/24 , C07D417/06 , C07D417/08 , C07D417/12 , C07D513/04 , C07F9/6547
摘要: Compounds having the formula are hepatitis C (HCV) polymerase inhibitors. Also disclosed are a composition and method for inhibiting hepatitis C (HCV) polymerase, processes for making the compounds, and synthetic intermediates employed in the processes.
摘要翻译: 具有下式的化合物是丙型肝炎(HCV)聚合酶抑制剂。 还公开了用于抑制丙型肝炎(HCV)聚合酶,制备该化合物的方法和该方法中使用的合成中间体的组合物和方法。
-
6.Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) 有权
标题翻译: 药物组合物作为二肽基肽酶-IV(DPP-IV)的抑制剂公开(公告)号:US20070049596A1
公开(公告)日:2007-03-01
申请号:US11510451
申请日:2006-08-25
申请人: Zhonghua Pei , Thomas Geldern , David Madar , Xiaofeng Li , Fatima Basha , Hong Yong , Kenton Longenecker , Bradley Backes , Andrew Judd , Matthew Mulhern , Kent Stewart
发明人: Zhonghua Pei , Thomas Geldern , David Madar , Xiaofeng Li , Fatima Basha , Hong Yong , Kenton Longenecker , Bradley Backes , Andrew Judd , Matthew Mulhern , Kent Stewart
IPC分类号: A61K31/498 , A61K31/495 , A61K31/445 , A61K31/47 , A61K31/277
CPC分类号: C07C211/48 , C07C211/40 , C07C217/52 , C07C217/54 , C07C217/74 , C07C217/84 , C07C217/86 , C07C225/22 , C07C229/42 , C07C229/48 , C07C229/60 , C07C233/43 , C07C233/78 , C07C235/46 , C07C237/24 , C07C237/30 , C07C237/42 , C07C255/54 , C07C255/58 , C07C311/22 , C07C311/36 , C07C317/22 , C07C317/36 , C07C2601/14 , C07C2601/16 , C07D207/16 , C07D209/08 , C07D209/48 , C07D211/46 , C07D211/60 , C07D211/62 , C07D213/30 , C07D213/38 , C07D213/64 , C07D213/68 , C07D213/74 , C07D213/82 , C07D217/04 , C07D263/56 , C07D263/60 , C07D277/04 , C07D277/64 , C07D295/135 , C07D295/185 , C07D295/205 , C07D317/66 , C07D319/18 , C07D333/34 , C07D333/38 , C07D409/04 , C07D487/04 , C07D491/048 , C07D495/04 , C07D498/04 , C07D513/04
摘要: The present invention relates to compounds, which inhibit dipeptidyl peptidase IV (DPP-IV) and are useful for the prevention or treatment of diabetes, especially type II, as well as hyperglycemia, metabolic syndrome, hyperinsulinemia, obesity, atherosclerosis, various immunomodulatory diseases, and other diseases.
摘要翻译: 本发明涉及抑制二肽基肽酶IV(DPP-IV)的化合物,其可用于预防或治疗糖尿病,特别是II型糖尿病,以及高血糖症,代谢综合征,高胰岛素血症,肥胖症,动脉粥样硬化,各种免疫调节疾病, 和其他疾病。
-
7.Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) 审中-公开
标题翻译: 药物组合物作为二肽基肽酶-IV(DPP-IV)的抑制剂公开(公告)号:US20060264433A1
公开(公告)日:2006-11-23
申请号:US11438881
申请日:2006-05-23
申请人: Bradley Backes , Gregory Hamilton , Hana Kopecka , Chunqiu Lai , Kenton Longenecker , David Madar , Zhonghua Pei , Kent Stewart , Thomas Von Geldern
发明人: Bradley Backes , Gregory Hamilton , Hana Kopecka , Chunqiu Lai , Kenton Longenecker , David Madar , Zhonghua Pei , Kent Stewart , Thomas Von Geldern
IPC分类号: A61K31/5377 , A61K31/506 , A61K31/502 , A61K31/496 , A61K31/53 , A61K31/4439 , A61K31/4025 , C07D413/02 , C07D409/02 , C07D403/02
CPC分类号: C07D403/14 , C07D207/14 , C07D401/12 , C07D401/14 , C07D403/04 , C07D409/14 , C07D413/14
摘要: The present invention relates to compounds, which inhibit dipeptidyl peptidase IV (DPP-IV) and are useful for the prevention or treatment of diabetes, especially type II diabetes, as well as hyperglycemia, syndrome X, hyperinsulinemia, obesity, atherosclerosis, various immunomodulatory diseases, and other diseases.
摘要翻译: 本发明涉及抑制二肽基肽酶IV(DPP-IV)并且可用于预防或治疗糖尿病,特别是II型糖尿病以及高血糖症,综合征X,高胰岛素血症,肥胖症,动脉粥样硬化,各种免疫调节疾病 ,等疾病。
-
公开(公告)号:US06593314B1
公开(公告)日:2003-07-15
申请号:US09668245
申请日:2000-09-22
申请人: Clarence J. Maring , Vincent L. Giranda , Yu Gui Gu , Stephen Hanessian , Dale J. Kempf , Darold L. Madigan , Kent Stewart , Vincent S. Stoll , Minghua Sun , Gary T. Wang , Jianchio Wang , Chen Zhao
发明人: Clarence J. Maring , Vincent L. Giranda , Yu Gui Gu , Stephen Hanessian , Dale J. Kempf , Darold L. Madigan , Kent Stewart , Vincent S. Stoll , Minghua Sun , Gary T. Wang , Jianchio Wang , Chen Zhao
IPC分类号: A61K31655
CPC分类号: C07C233/52 , C07C247/12 , C07C2601/16 , C07D303/38 , C07D303/40
摘要: The present invention provides compounds of formula Ia and Ib or a pharmaceutically acceptable salt, prodrug, or ester thereof, useful in the inhibition of neuraminidase enzymes from disease-causing microorganisms, especially influenza neuraminidase, pharmaceutical formulations containing same, processes and intermediates for preparing said compounds, as well as methods of using said compounds, including preventing and treating diseases caused by microorganisms having said neuraminidase enzyme.
摘要翻译: 本发明提供了可用于抑制致病微生物,特别是流感神经氨酸酶的神经氨酸酶的药学上可接受的盐,前药或酯的式Ia化合物和Ibor,其含有其的药物制剂,用于制备所述化合物的方法和中间体 以及使用所述化合物的方法,包括预防和治疗由具有所述神经氨酸酶的微生物引起的疾病。
-
-
-
-
-
-
-